Abstract
Background
We present two children with acute tubulointerstitial nephritis (ATIN) caused by leptospirosis in a 12-year-old boy and hantavirus in a 10-year-old girl. The role of glucocorticoids in the management of ATIN triggered by infectious agents is unclear.
Case-diagnosis/treatment
Both children were hospitalized with jaundice, elevated serum creatinine, and thrombocytopenia. There was no oliguria or hypertension. Urine analysis revealed tubular proteinuria. Kidney biopsy was performed on one patient and showed tubulointerstitial inflammation with mild mesangial proliferation. Both patients were treated with glucocorticoids in view of deteriorating kidney function with respective serum creatinine values of 5.2 and 4.1 mg/dl. Both children exhibited an excellent clinical and biochemical response to treatment. Neither of the patients required dialysis. Positive serology test results indicated a recent leptospirosis and hantavirus infection.
Conclusions
Leptospirosis and hantavirus associated ATIN share common clinical and biochemical features. Due to the low incidence in Europe these infectious causes of kidney dysfunction may be overlooked. Glucocorticoids may be considered in the management of ATIN.
Similar content being viewed by others
Data Availability
All data underlying the results are available as part of the article.
References
Ulinski T, Sellier-Leclerc AL, Tudorache E, Bensman A, Aoun B (2012) Acute tubulointerstitial nephritis. Pediatr Nephrol 27:1051–1057
Ruebner RL, Fadrowski JJ (2019) Tubulointerstitial nephritis. Pediatr Clin North Am 66:111–119
Dusek J, Pejcoch M, Kolsky A, Seeman T, Nemec V, Stejskal J, Vondrak K, Janda J (2006) Mild course of Puumala nephropathy in children in an area with sporadic occurrence Hantavirus infection. Pediatr Nephrol 21:1889–1892
Bakelants E, Peetermans W, Lagrou K, Meersseman W (2020) Clinical and biochemical differences between hantavirus infection and leptospirosis: a retrospective analysis of a patient series in Belgium. Acta Clin Belg 75:185–192
Andrade L, de Francesco DE, Seguro AC (2008) Leptospiral nephropathy. Semin Nephrol 28:383–394
Martinuč Bergoč M, Lindič J, Kovač D, Ferluga D, Pajek J (2013) Successful treatment of severe hantavirus nephritis with corticosteroids: a case report and literature review. Ther Apher Dial 17:402–406
Yang CW (2018) Leptospirosis renal disease: emerging culprit of chronic kidney disease unknown etiology. Nephron 138:129–136
Ferluga D, Vizjak A (2008) Hantavirus nephropathy. J Am Soc Nephrol 19:1653–1658
Clarkson MR, Giblin L, O’Connell FP, O’Kelly P, Walshe JJ, Conlon P, O’Meara Y, Dormon A, Campbell E, Donohoe J (2004) Acute interstitial nephritis: clinical features and response to corticosteroid therapy. Nephrol Dial Transplant 19:2778–2783
González E, Gutiérrez E, Galeano C, Chevia C, de Sequera P, Bernis C, Parra EG, Delgado R, Sanz M, Ortiz M, Goicoechea M, Quereda C, Olea T, Bouarich H, Hernández Y, Segovia B, Praga M (2008) Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritis. Kidney Int 73:940–946
Jahnukainen T, Saarela V, Arikoski P, Ylinen E, Rönnholm K, Ala-Houhala M, Nuutinen M (2013) Prednisone in the treatment of tubulointerstitial nephritis in children. Pediatr Nephrol 28:1253–1260
Minor K, Mohan A (2013) Severe leptospirosis: treatment with intravenous corticosteroids and supportive care. Am J Emerg Med 31:449.e441-e442
Tapia M, Mansilla C, Jose T, Vera M (2000) Hantavirus pulmonary syndrome, clinical experience in diagnosis and treatment. Hospital Coyhaique-Chile Rev Chil Infect 17:258–269
Vial PA, Valdivieso F, Ferres M, Riquelme R, Rioseco ML, Calvo M, Castillo C, Díaz R, Scholz L, Cuiza A, Belmar E, Hernandez C, Martinez J, Lee SJ, Mertz GJ (2013) High-dose intravenous methylprednisolone for hantavirus cardiopulmonary syndrome in Chile: a double-blind, randomized controlled clinical trial. Clin Infect Dis 57:943–951
Lupuşoru G, Lupuşoru M, Ailincăi I, Bernea L, Berechet A, Spătaru R, Ismail G (2021) Hanta hemorrhagic fever with renal syndrome: a pathology in whose diagnosis kidney biopsy plays a major role (Review). Exp Ther Med 22:984
Reis EA, Hagan JE, Ribeiro GS, Teixeira-Carvalho A, Martins-Filho OA, Montgomery RR, Shaw AC, Ko AI, Reis MG (2013) Cytokine response signatures in disease progression and development of severe clinical outcomes for leptospirosis. PLoS Negl Trop Dis 7:e2457
Win T, Tabei K, Mukadi P, Edwards T, Smith C, Lee N (2022) Corticosteroids for treatment of leptospirosis. Cochrane Database Syst Rev. https://www.cochrane.org/CD014935/LIVER_corticosteroids-treatment-leptospirosis. Accessed 11 Dec 2022
Rodrigo C, Lakshitha de Silva N, Goonaratne R, Samarasekara K, Wijesinghe I, Parththipan B, Rajapakse S (2014) High dose corticosteroids in severe leptospirosis: a systematic review. Trans R Soc Trop Med Hyg 108:743–750
Miettinen MH, Mäkelä SM, Ala-Houhala IO, Huhtala HS, Kööbi T, Vaheri AI, Pasternack AI, Pörsti IH, Mustonen JT (2006) Ten-year prognosis of Puumala hantavirus-induced acute interstitial nephritis. Kidney Int 69:2043–2048
Novo R, Gagnadoux MF, Le Guenno Y, Gubler MC, Niaudet P, Guyot C, Broyer M (1999) Chronic renal failure after Puumala virus infection. Pediatr Nephrol 13:934–935
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Matthys, A., Dehoorne, J., Dendooven, A. et al. Favorable course of leptospirosis and hantavirus-induced acute tubulointerstitial nephritis under corticosteroid treatment. Pediatr Nephrol 38, 3853–3857 (2023). https://doi.org/10.1007/s00467-023-05942-w
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-023-05942-w